Stockreport

REGENXBIO Sees Positive Results For Macular Degeneration Therapy [Yahoo! Finance]

REGENXBIO Inc.  (RGNX) 
Last regenxbio inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.regenxbio.com
PDF Two years of data were published in The Lancet regarding the ongoing trials of ABBV-RGX-314, its potential one-time gene therapy for the treatment of so-called wet AMD. [Read more]